InvestorsHub Logo
Followers 2
Posts 105
Boards Moderated 0
Alias Born 06/03/2019

Re: None

Tuesday, 07/30/2019 2:33:36 PM

Tuesday, July 30, 2019 2:33:36 PM

Post# of 111073
I have been doing research for a while too. One thing you learn quickly is conventional wisdom is often wrong. And stem cell therapies often fail. With two different dosages was one more successful? Have they optimized the dosing? Did either work? Also there was a lot of optimism in cardiac tissue regeneration after MI in the cardiology field and stem cell therapy proved terribly disappointing. ED is an easier target but I am not convinced / very skeptical that this company has a successful product. Especially since after 11 months they still are sitting on the clinical trial data and apparently not even submitted it to a peer reviewed medical journal or to an academic conference. Actions speak louder than words and I saw enough with this company. I am out thousands from this company but learned an important lesson and should have sold much sooner
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CELZ News